ACT-TIL and ANV419 for Advanced Melanoma.
ACT-TIL and ANV419 for Advanced Melanoma.
Active, not recruiting · NCT05869539 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACT-TIL and ANV419 for Advanced Melanoma. | Advanced Melanoma | Active, not recruiting | Phase 1 | 2026-02-27 | NCT05869539 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anaveon AG | 1 |
| University Hospital, Basel, Switzerland | 243 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Basel | Basel | Switzerland | 9 |